191 related articles for article (PubMed ID: 26844275)
1. Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial.
Azria D; Riou O; Castan F; Nguyen TD; Peignaux K; Lemanski C; Lagrange JL; Kirova Y; Lartigau E; Belkacemi Y; Bourgier C; Rivera S; Noël G; Clippe S; Mornex F; Hennequin C; Kramar A; Gourgou S; Pèlegrin A; Fenoglietto P; Ozsahin EM
EBioMedicine; 2015 Dec; 2(12):1965-73. PubMed ID: 26844275
[TBL] [Abstract][Full Text] [Related]
2. Association of CD4
Veldwijk MR; Seibold P; Botma A; Helmbold I; Sperk E; Giordano FA; Gürth N; Kirchner A; Behrens S; Wenz F; Chang-Claude J; Herskind C
Clin Cancer Res; 2019 Jan; 25(2):562-572. PubMed ID: 30327309
[TBL] [Abstract][Full Text] [Related]
3. Concurrent or sequential letrozole with adjuvant breast radiotherapy: final results of the CO-HO-RT phase II randomized trial.
Bourgier C; Kerns S; Gourgou S; Lemanski C; Gutowski M; Fenoglietto P; Romieu G; Crompton N; Lacombe J; Pèlegrin A; Ozsahin M; Rosenstein B; Azria D
Ann Oncol; 2016 Mar; 27(3):474-80. PubMed ID: 26681684
[TBL] [Abstract][Full Text] [Related]
4. RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort study.
Mirjolet C; Merlin JL; Truc G; Noël G; Thariat J; Domont J; Sargos P; Renard-Oldrini S; Ray-Coquard I; Liem X; Chevreau C; Lagrange JL; Mahé MA; Collin F; Bonnetain F; Bertaut A; Maingon P
EBioMedicine; 2019 Mar; 41():420-426. PubMed ID: 30827931
[TBL] [Abstract][Full Text] [Related]
5. A Review of Radiation-Induced Lymphocyte Apoptosis as a Predictor of Late Toxicity After Breast Radiotherapy.
Fhoghlú MN; Barrett S
J Med Imaging Radiat Sci; 2019 Jun; 50(2):337-344. PubMed ID: 31176443
[TBL] [Abstract][Full Text] [Related]
6. Time-Dependent ROC Curve Analysis for Assessing the Capability of Radiation-Induced CD8 T-Lymphocyte Apoptosis to Predict Late Toxicities after Adjuvant Radiotherapy of Breast Cancer Patients.
Touraine C; Winter A; Castan F; Azria D; Gourgou S
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835370
[TBL] [Abstract][Full Text] [Related]
7. Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial.
Azria D; Belkacemi Y; Romieu G; Gourgou S; Gutowski M; Zaman K; Moscardo CL; Lemanski C; Coelho M; Rosenstein B; Fenoglietto P; Crompton NE; Ozsahin M
Lancet Oncol; 2010 Mar; 11(3):258-65. PubMed ID: 20138810
[TBL] [Abstract][Full Text] [Related]
8. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.
Bartelink H; Maingon P; Poortmans P; Weltens C; Fourquet A; Jager J; Schinagl D; Oei B; Rodenhuis C; Horiot JC; Struikmans H; Van Limbergen E; Kirova Y; Elkhuizen P; Bongartz R; Miralbell R; Morgan D; Dubois JB; Remouchamps V; Mirimanoff RO; Collette S; Collette L;
Lancet Oncol; 2015 Jan; 16(1):47-56. PubMed ID: 25500422
[TBL] [Abstract][Full Text] [Related]
9. Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial.
Bourgier C; Castan F; Riou O; Nguyen TD; Peignaux K; Lemanski C; Lagrange JL; Kirova Y; Lartigau E; Belkacemi Y; Rivera S; Noël G; Clippe S; Mornex F; Hennequin C; Gourgou S; Brengues M; Fenoglietto P; Ozsahin EM; Azria D
Oncotarget; 2018 Mar; 9(21):15757-15765. PubMed ID: 29644007
[TBL] [Abstract][Full Text] [Related]
10. [Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conservative surgery enhances late toxicities].
Toledano A; Garaud P; Serin D; Fourquet A; Bosset JF; Miny-Buffet J; Favre A; Azria D; Body G; Le Floch O; Calais G
Cancer Radiother; 2006 Jun; 10(4):158-67. PubMed ID: 16632399
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 patients treated with a prospective margin-directed policy.
Livi L; Meattini I; Franceschini D; Saieva C; Meacci F; Marrazzo L; Gerlain E; Desideri I; Scotti V; Nori J; Sanchez LJ; Orzalesi L; Bonomo P; Greto D; Bianchi S; Biti G
Radiother Oncol; 2013 Aug; 108(2):273-8. PubMed ID: 23490271
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated irradiation of infra-supraclavicular lymph nodes after axillary dissection in patients with breast cancer post-conservative surgery: impact on late toxicity.
Guenzi M; Blandino G; Vidili MG; Aloi D; Configliacco E; Verzanini E; Tornari E; Cavagnetto F; Corvò R
Radiat Oncol; 2015 Aug; 10():177. PubMed ID: 26289040
[TBL] [Abstract][Full Text] [Related]
13. CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients.
Ozsahin M; Crompton NE; Gourgou S; Kramar A; Li L; Shi Y; Sozzi WJ; Zouhair A; Mirimanoff RO; Azria D
Clin Cancer Res; 2005 Oct; 11(20):7426-33. PubMed ID: 16243816
[TBL] [Abstract][Full Text] [Related]
14. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis for prediction of radiotherapy late toxicity: lymphocyte subset sensitivity and potential effect of TP53 Arg72Pro polymorphism.
Fuentes-Raspall MJ; Caragol I; Alonso C; Ramón y Cajal T; Fisas D; Seoane A; Carvajal N; Bonache S; Díez O; Gutiérrez-Enríquez S
Apoptosis; 2015 Mar; 20(3):371-82. PubMed ID: 25398538
[TBL] [Abstract][Full Text] [Related]
16. Patients with N1 breast cancer: who could benefit from supraclavicular fossa radiotherapy?
Viani GA; Godoi da Silva LB; Viana BS
Breast; 2014 Dec; 23(6):749-53. PubMed ID: 25231194
[TBL] [Abstract][Full Text] [Related]
17. Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity.
Lacombe J; Brengues M; Mangé A; Bourgier C; Gourgou S; Pèlegrin A; Ozsahin M; Solassol J; Azria D
Radiat Oncol; 2019 Aug; 14(1):142. PubMed ID: 31399108
[TBL] [Abstract][Full Text] [Related]
18. Hypofractionated irradiation in elderly patients with breast cancer after breast conserving surgery and mastectomy : Analysis of 205 cases.
Doré M; Cutuli B; Cellier P; Campion L; Le Blanc M
Radiat Oncol; 2015 Aug; 10():161. PubMed ID: 26238442
[TBL] [Abstract][Full Text] [Related]
19. Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke.
Woodward WA; Giordano SH; Duan Z; Hortobagyi GN; Buchholz TA
Cancer; 2006 Jun; 106(12):2556-62. PubMed ID: 16691617
[TBL] [Abstract][Full Text] [Related]
20. Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy.
Azria D; Ozsahin M; Kramar A; Peters S; Atencio DP; Crompton NE; Mornex F; Pèlegrin A; Dubois JB; Mirimanoff RO; Rosenstein BS
Clin Cancer Res; 2008 Oct; 14(19):6284-8. PubMed ID: 18829510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
